Detailed company information
Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide. Established in 1998, the Boston, Massachusetts-based firm initially operated as Microbia, Inc. before officially rebranding to Ironwood Pharmaceuticals, Inc. in April 2008.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 06, 2026
Earnings Transcript for 2026 - Q1Released: May 07, 2026
Earnings Transcript for 2025 - Q4Released: Feb 25, 2026
Earnings Transcript for 2024 - Q4Released: Feb 27, 2025
Earnings Transcript for 2024 - Q3Released: Nov 07, 2024
Earnings Transcript for 2024 - Q2Released: Aug 09, 2024
Earnings Transcript for 2024 - Q1Released: May 09, 2024
Earnings Transcript for 2023 - Q4Released: Feb 15, 2024
Earnings Transcript for 2023 - Q3Released: Nov 09, 2023
Earnings Transcript for 2023 - Q2Released: Aug 08, 2023
Earnings Transcript for 2023 - Q1Released: May 06, 2023
Earnings Transcript for 2022 - Q4Released: Feb 16, 2023
Earnings Transcript for 2022 - Q3Released: Nov 03, 2022
Earnings Transcript for 2022 - Q2Released: Aug 06, 2022
Earnings Transcript for 2022 - Q1Released: May 08, 2022
Earnings Transcript for 2021 - Q4Released: Feb 17, 2022
Earnings Transcript for 2021 - Q3Released: Nov 06, 2021
Earnings Transcript for 2021 - Q2Released: Aug 08, 2021
Earnings Transcript for 2021 - Q1Released: May 06, 2021
Earnings Transcript for 2020 - Q4Released: Feb 17, 2021
Earnings Transcript for 2020 - Q3Released: Nov 05, 2020
Earnings Transcript for 2020 - Q2Released: Aug 09, 2020
Earnings Transcript for 2020 - Q1Released: May 07, 2020
Earnings Transcript for 2019 - Q4Released: Feb 13, 2020
ANIP ANI Pharmaceuticals, Inc.
Dafinchi
